Scientific Advisory Board

Professor Robert Geoff Richards, FBSE, FIOR.

Professor Richards has worked at the AO Research Institute in Davos, Switzerland since 1991. Since 2009 he has been the director with 100 multidisciplinary scientists who undertake cutting-edge research in regenerative medicine, tissue engineering, biomaterials and implant science. The research contributes to the AO Foundation’s educational courses dedicated to promoting excellence in patient care in musculoskeletal disorders and trauma where over 58,000 surgeons attend 830 such educational events globally each year.
In his 10 years as director he has brought the institute up to international standards ISO 9001: 2015 and certified the institute as a medical device manufacturer EN ISO 13485: 2016 to allow clinical evaluation of the institute's innovations. He brought the Preclinical Facility to AAALAC  accreditation (Association for Assessment and Accreditation of Laboratory Animal Care International) in early 2013 and achieved Good Laboratory Practice level in 2016 (GLP compliant test facility for biocompability and efficacy with medical devices and pharmaceuticals).
He is author on over 220 peer reviewed research articles and numerous reviews and book chapters. His research work on titanium implant interfaces in trauma has translated to major improvements in the design and manufacture of fracture fixation devices by the largest trauma company in the world, Synthes which has improved patient care in the field. In 1999 he co-founded eCM journal, arguably the first online only, open access journal in the world, a pioneer in open access publishing. This concept disrupted the publishing field in science, which is now standard practice. In 2016 founded the International College of Fellows for ICORS (International Combined Orthopaedic Research Societies).

Since becoming Global president of TERMIS, he has developed and implemented the following steps for best practice in governance.

  1. New mission for TERMIS. https://www.termis.org/our-mission
  2. A Diversity statement https://www.termis.org/diversity-statement
  3. Created the first Code of Ethics policy. (https://www.termis.org/code-ethics-conduct)
  4. In 2020 he intends to tackle the bylaws and start on activities for FTERM (our fellows).

 

Professor Abhay Pandit

Professor Abhay Pandit is the Established Professor in Biomaterials. He is the Director of a Science Foundation Ireland funded Centre for Research in Medical Devices (CÚRAM) at the the National University of Ireland, Galway. He obtained a PhD from the University of Alabama at Birmingham, where his postgraduate work focussed on the modification of a fibrin scaffold to deliver a therapeutic biomolecule and resulted in a clinical trial at the Burn Centre. Prof Pandit has over twenty-five years of experience in the field of biomaterials. After a seven-year stint in industry he has worked in academia for the last twelve years. His research is funded by Science Foundation Ireland, the 7th EU Framework programme, Enterprise Ireland, Health Research Board, the AO Foundation and industry sources, and in excess of €78 million. He is the author of 4 patents and has licensed three technologies to medical device companies. He has published more than 180 manuscripts in high-impact factor publications. He was inducted as an International Fellow in Biomaterials Science and Engineering by the International Union of Societies for Biomaterials Science and Engineering (IUSBSE). He has been elected as a Council Member of the Tissue Engineering and Regenerative Medicine and the International Society and European Society for Biomaterials

 

Professor Dato’ Dr. Ruszymah Bt Hj Idrus

She is the pioneering researcher in the field of Tissue Engineering and Regenerative Medicine in Malaysia. She is the Professor of Physiology at the Department of Physiology, Faculty of Medicine, Universiti Kebangsaan Malaysia (UKM). She has been the founder Head of the Tissue Engineering Center at UKM Medical Center. She is also the founder President of the Tissue Engineering Society of Malaysia (TESMA) and a Council Member of the Tissue Engineering and Regenerative Medicine International Society-Asia Pacific Chapter (TERMIS-AP) when it was first initiated.